Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

9.04
+0.01000.11%
Pre-market: 8.92-0.1200-1.33%09:16 EST
Volume:3.39M
Turnover:30.98M
Market Cap:563.12M
PE:-2.61
High:9.49
Open:9.08
Low:9.00
Close:9.03
52wk High:71.50
52wk Low:7.76
Shares:62.29M
Float Shares:40.64M
Volume Ratio:0.32
T/O Rate:8.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4602
EPS(LYR):-3.4602
ROE:-207.10%
ROA:-16.77%
PB:2.83
PE(LYR):-2.61

Loading ...

What's Going On With uniQure Stock Wednesday?

Benzinga_recent_news
·
Yesterday

Berger Montague alerts uniQure investors to class action lead plaintiff deadline

Reuters
·
Yesterday

Rosen Law Firm Urges uniQure Investors to Meet April 13 Lead Plaintiff Deadline

Reuters
·
Yesterday

These Analysts Cut Their Forecasts On uniQure Following Q4 Results

Benzinga
·
Mar 03

Chardan Cuts Price Target on uniQure to $16 From $53, Keeps Buy Rating

MT Newswires Live
·
Mar 03

uniQure Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 03

uniQure price target lowered to $16 from $53 at Chardan

TIPRANKS
·
Mar 03

Uniqure Nv : Mizuho Cuts to Neutral From Outperform; Cuts Target Price to $12 From $33

THOMSON REUTERS
·
Mar 03

Uniqure Nv : Wells Fargo Cuts to Equal Weight From Overweight; Cuts Target Price to $15 From $60

THOMSON REUTERS
·
Mar 03

Barclays Reaffirms Their Hold Rating on uniQure (QURE)

TIPRANKS
·
Mar 03

uniQure Faces 2026 Shift to Dutch Large Company Regime, Curbing Direct Shareholder Control Over Board Appointments

TIPRANKS
·
Mar 03

uniQure (QURE) was downgraded to a Hold Rating at Mizuho Securities

TIPRANKS
·
Mar 03

UniQure (QURE) Posts Q4 Loss Of US$37.1m Reinforcing Profitability Concerns

Simply Wall St.
·
Mar 03

FDA Mandates Phase III Trial for uniQure's Huntington's Disease Gene Therapy, Blocking Market Approval and Sending Shares Down 33%

Stock News
·
Mar 03

Rosen Law Firm Sets April 13 Lead Plaintiff Deadline in uniQure Securities Class Action

Reuters
·
Mar 03

uniQure downgraded to Equal Weight from Overweight at Wells Fargo

TIPRANKS
·
Mar 03

Top Midday Decliners

MT Newswires Live
·
Mar 03

uniQure Raised to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 03

uniQure downgraded at RBC after ‘disappointing’ Huntington’s update

TIPRANKS
·
Mar 03

Uniqure Nv : RBC Cuts to Sector Perform From Outperform; Cuts Target Price to $11 From $45

THOMSON REUTERS
·
Mar 03